论文信息 - Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease. - 字舞流文

Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease.

C. Denton | A. Manes | N. Galiè | F. Dardi | M. Palazzini | A. Esler | L. Varanese | Baohui Li | G. Mazzanti | Cathi Harmon

[1] E. Grünig,et al. Treatment of Pulmonary Arterial Hypertension in Connective Tissue Disease , 2012, Drugs.

[2] B. Brundage,et al. Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension study. , 2012, Journal of the American College of Cardiology.

[3] Christopher S Coffey,et al. Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) , 2010, Circulation.

[4] M. Humbert,et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension , 2010, European Respiratory Journal.

[5] D. Badesch,et al. Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol , 2009, The Journal of Rheumatology.

[6] G. Filippatos,et al. Guidelines for the diagnosis and treatment of pulmonary hypertension , 2009 .

[7] B. Brundage,et al. Tadalafil Therapy for Pulmonary Arterial Hypertension , 2009, Circulation.

[8] Y. Allanore,et al. Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials , 2007, Annals of the rheumatic diseases.

[9] A. Branzi,et al. Pulmonary arterial hypertension associated to connective tissue diseases , 2005, Lupus.